Clinical Trial Update: Safety and Efficacy of Botulinum Toxin A in Patients With Trigeminal Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and efficacy of Botulinum Toxin A in trigeminal neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Henrik Schytz | Conditions: Trigeminal Neuralgia | Phase 3 | Status: UNKNOWN